Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

PURPOSE: Clinical guidelines recommend febuxostat as first-line pharmacologic urate-lowering therapy for patients with gout to achieve a goal serum uric acid (sUA) <6 mg/dL; however, little is known about other contributing factors. This study identified clinical characteristics of patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheer, Richard, Null, Kyle D, Szymanski, Keith A, Sudharshan, Lavanya, Banovic, Jennifer, Pasquale, Margaret K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644566/
https://www.ncbi.nlm.nih.gov/pubmed/29066924
http://dx.doi.org/10.2147/CEOR.S139939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644566/
https://www.ncbi.nlm.nih.gov/pubmed/29066924
http://dx.doi.org/10.2147/CEOR.S139939

Ejemplares similares